Next Article in Journal
Medium Chain Acyl-CoA Dehydrogenase Deficiency in a Premature Infant
Previous Article in Journal
The Role of Interleukin-6 in the Early Diagnosis of Sepsis in Premature Infants
 
 
Pediatric Reports is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Atypical Clinical Presentation and Successful Treatment With Oral Cholic Acid of a Child with Defective Bile Acid Synthesis due to a Novel Mutation in the HSD3B7 Gene

by
Grazia Bossi
1,*,
Giuseppe Giordano
1,
Gaetana Anna Rispoli
1,
Giuseppe Maggiore
1,
Mauro Naturale
2,
Daniela Marchetti
1 and
Maria Iascone
5
1
Pediatric Department, IRCCS Foundation Policlinico San Matteo, Pavia, Italy
2
Mass Spectrometry Laboratory, Women’s and Children’s Health Department, University of Padua, Institute for Pediatric Research (IRP), Padua, Italy
3
Department of Radiology, US Pediatric Radiology, IRCCS Foundation Policlinico San Matteo, Pavia, Italy
4
Department of Medical Science, Pediatric Section, University of Ferrara, Italy
5
Laboratory of Genetic Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy
*
Author to whom correspondence should be addressed.
Pediatr. Rep. 2017, 9(3), 7266; https://doi.org/10.4081/pr.2017.7266
Submission received: 19 June 2017 / Revised: 18 August 2017 / Accepted: 18 August 2017 / Published: 10 October 2017

Abstract

We report definitive diagnosis and effective treatment with oral cholic acid in one Italian male child affected by 3β- hydroxy-Δ5-C27-steroid dehydrogenase (3β- HSD) deficiency. He presented with failure to thrive, hepatomegaly and multiple cystic images in kidneys; no biochemical evidence of cholestasis. Large amounts of bile acid metabolites was detected in urine by fast atom bombardment ionization mass spectrometry (FAB-MS). HSDH3B7 gene analysis identified one mutation in intron 4, at nucleotide 432, G>A substitution that has never been reported before.The replacement therapy with oral cholic acid started early after the diagnosis and is still ongoing. Three years later hepatomegaly is no longer evident, liver function is normal and the child is growing regularly. In our experience, clinical features of 3β-HSD deficiency can be very poor and even cholestasis can lack at diagnosis. Early replacement therapy with cholic acid is safe and leads to clinical and biochemical control of the disease.
Keywords: genetic cholestasis; cholic acid genetic cholestasis; cholic acid

Share and Cite

MDPI and ACS Style

Bossi, G.; Giordano, G.; Rispoli, G.A.; Maggiore, G.; Naturale, M.; Marchetti, D.; Iascone, M. Atypical Clinical Presentation and Successful Treatment With Oral Cholic Acid of a Child with Defective Bile Acid Synthesis due to a Novel Mutation in the HSD3B7 Gene. Pediatr. Rep. 2017, 9, 7266. https://doi.org/10.4081/pr.2017.7266

AMA Style

Bossi G, Giordano G, Rispoli GA, Maggiore G, Naturale M, Marchetti D, Iascone M. Atypical Clinical Presentation and Successful Treatment With Oral Cholic Acid of a Child with Defective Bile Acid Synthesis due to a Novel Mutation in the HSD3B7 Gene. Pediatric Reports. 2017; 9(3):7266. https://doi.org/10.4081/pr.2017.7266

Chicago/Turabian Style

Bossi, Grazia, Giuseppe Giordano, Gaetana Anna Rispoli, Giuseppe Maggiore, Mauro Naturale, Daniela Marchetti, and Maria Iascone. 2017. "Atypical Clinical Presentation and Successful Treatment With Oral Cholic Acid of a Child with Defective Bile Acid Synthesis due to a Novel Mutation in the HSD3B7 Gene" Pediatric Reports 9, no. 3: 7266. https://doi.org/10.4081/pr.2017.7266

Article Metrics

Back to TopTop